Concourse Financial Group Securities, Inc. Ionis Pharmaceuticals Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 26 shares of IONS stock, worth $1,096. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26
Previous 19
36.84%
Holding current value
$1,096
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$584 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$533 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$435 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$348 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$277 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.99B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...